Prelude Therapeutics
在场
高管
查看带有其 20 名主要高管的组织结构图
Prelude Therapeutics 搜索最多的简介
- Kris Vaddi, Chief Executive Officer and Director
- Paul Friedman, Chairman of the Board
- David Bonita, Director
创建提醒
跟踪 Prelude Therapeutics 的高管变动
生物技术
Prelude Therapeutics 拥有 2,337 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Aadi Bioscience 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
- OraSure Technologies has announced the acquisition of Sherlock Biosciences (公布2024十二月20号).
- SiteOne Therapeutics 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
生物技术 行业的其他推荐联系人
消息
Prelude Therapeutics 的最新新闻稿
- News Releases - Prelude Therapeutics
- News Releases - Prelude Therapeutics
- News Releases - Prelude Therapeutics
- News Releases - Prelude Therapeutics
- Prelude Announces Strategic Pipeline Progress and Updates, including its Partnership with AbCellera, and Reports Third Quarter Financial Results - Prelude Therapeutics
- Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology - Prelude Therapeutics
- Prelude Announces Multiple Clinical and Preclinical Poster Presentations at AACR-NCI-EORTC International Conference - Prelude Therapeutics
- Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in May - Prelude Therapeutics
- Prelude Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update - Prelude Therapeutics
- Prelude Therapeutics Announces First Quarter 2022 Financial Results and Operations Update - Prelude Therapeutics
- View more press releases Close
通过电子邮件
